Targeting of Captopril to the Kidney Reduces Renal Angiotensin-Converting Enzyme Activity without Affecting Systemic Blood Pressure by Kok, R J, Haverdings, R F G, Grijpstra, F, Koiter, J, Moolenaar, F, de Zeeuw, D, Meijer, D K F

Get full text

Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats by Haverdings, R G F, Haas, M, Navis, G J, Van Loenen‐Weemaes, A M A, Meijer, D K F, De Zeeuw, D, Moolenaar, F

Get full text

An algorithm to personalize nerve sparing in men with unilateral high-risk prostate cancer by Martini, A., Soeterik, T.F.W., Haverdings, H., Rahota, R-G., Checcucci, E., De Cillis, S., Cirulli, G.O., Hermanns, T., Fankhauser, C.D., Afferi, L., Mattei, A., Kesch, C., Heidegger, I., Preisser, F., Zattoni, F., Marquis, A., Marra, G., Briganti, A., Porpiglia, F., Van Basten, J.P., Van Den Bergh, R.C.N., Van Melick, H.H.E., Ploussard, G., Gandaglia, G., Valerio, M.

Get full text

Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats by Haverdings, R Folgert G, Haas, Marijke, Navis, Gerjan, Loenen‐Weemaes, Anne‐miek, Meijer, Dirk K F, Zeeuw, Dick, Moolenaar, Frits

Get full text